Covishield produced more antibodies than Covaxin, claims study

A new study on coronavirus vaccinations in healthcare workers in India has revealed that two doses of the Covishield vaccine have produced more antibodies than two doses of Covaxin. The first Indian study involving doctors and nurses who received both doses of either of the two COVID-19 vaccines claimed that the seropositivity rates to anti-spike antibodies were significantly higher in Covishield recipients when compared to Covaxin after the first dose.

Leave a Reply

Your email address will not be published. Required fields are marked *

Covishield produced more antibodies than Covaxin, claims study

A new study on coronavirus vaccinations in healthcare workers in India has revealed that two doses of the Covishield vaccine have produced more antibodies than two doses of Covaxin. The first Indian study involving doctors and nurses who received both doses of either of the two COVID-19 vaccines claimed that the seropositivity rates to anti-spike antibodies were significantly higher in Covishield recipients when compared to Covaxin after the first dose.

Leave a Reply

Your email address will not be published. Required fields are marked *